Oncology practice patterns in the use of hematopoietic growth factors

被引：8
|
作者：
Parsons, SK
机构：
[1] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
来源：
CURRENT OPINION IN PEDIATRICS | 2000年 / 12卷 / 01期
关键词：
D O I：
10.1097/00008480-200002000-00003
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Recombinant hematopoietic growth factors were introduced into clinical practice a decade ago: erythropoietin in 1989, granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in 1991, and interleukin-11 in 1997, The role of these agents in supportive therapy for children with cancer is still under considerable evaluation. This pediatric-based review summarizes current clinical applications, practice guidelines, and practice patterns for hematopoietic growth factors in the supportive care of children with cancer. It also discusses ongoing controversies and unanswered questions. Curr Opin Pediatr 2000, 12:10-17 (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码：10 / 17
页数：8
相关论文
共 50 条
12345